Fat, cachexia, and the right ventricle in heart failure: A web of complicity

Journal of the American College of Cardiology

Volumn 62, Issue 18, 2013, Pages 1671-1673

  Mehra, Mandeep R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

body composition; cardiac cachexia; heart failure; obesity paradox; right ventricular function

Indexed keywords

C REACTIVE PROTEIN; NATRIURETIC FACTOR;

ANEMIA; BODY COMPOSITION; CACHEXIA; CARDIORENAL SYNDROME; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; FAT MASS; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; LEAN BODY WEIGHT; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LIPOLYSIS; MALNUTRITION; NOTE; NUTRITIONAL STATUS; OBESITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RISK ASSESSMENT; WEIGHT REDUCTION;

EID: 84886389034     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.07.021     Document Type: Editorial

References (21)

1. S. von Haehling, M. Lainscak, J. Springer, and S.D. Anker Cardiac cachexia: a systematic overview Pharmacol Ther 121 2009 227 252
2. C.J. Lavie, M.R. Mehra, and R.V. Milani Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 26 2005 5 7
3. V. Melenovsky, M. Kotrc, and B.A. Borlaug Relationships between right ventricular function, body composition, and prognosis in advanced heart failure J Am Coll Cardiol 62 2013 1660 1670
4. S.R. Wilson, S. Ghio, L. Scelsi, and E.M. Horn Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension) Prog Cardiovasc Dis 55 2012 104 118
5. T. Damy, S. Ghio, and A.S. Rigby Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure) J Am Coll Cardiol 61 2013 2153 2160
6. J.C. Fang, T. DeMarco, and M.M. Givertz World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult - a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 31 2012 913 933
7. J.A. Morgan, G. Paone, and H.W. Nemeh Impact of continuous-flow left ventricular assist device support on right ventricular function J Heart Lung Transplant 32 2013 398 403
8. J.R. Brown, P.A. Uber, and M.R. Mehra The progressive cardiorenal syndrome in heart failure: mechanisms and therapeutic insights Curr Treat Options Cardiovasc Med 10 2008 342 348
9. W. Mullens, Z. Abrahams, and G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
10. J. Meadows, and K. Jenkins Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment Cardiol Young 21 2011 363 377
11. C.W. Le Roux, M.A. Ghatei, J.S.R. Gibbs, and S.R. Bloom The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension Heart 91 2005 241 242
12. S.D. Anker, and R. Sharma The syndrome of cardiac cachexia Int J Cardiol 85 2002 51 66
13. T.S. Kato, G.R. Stevens, and J. Jiang Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation J Heart Lung Transplant 32 2013 333 340
14. M. Lafontan, C. Moro, M. Berlan, F. Crampes, C. Sengenes, and J. Galitzky Control of lipolysis by natriuretic peptides and cyclic GMP Trends Endocrinol Metab 19 2008 130 137
15. S.K. Das, S. Eder, and S. Schauer Adipose triglyceride lipase contributes to cancer-associated cachexia Science 333 2011 233 238
16. M. Suzuki, M. Narita, and M. Ashikawa Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia Synapse 66 2012 747 751
17. S. Palus, R. Schur, and Y.J. Akashi Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model PLoS One 6 2011 e26865
18. H.Q. Han, X. Zhou, W.E. Mitch, and A.L. Goldberg Myostatin/activin pathway antagonism: molecular basis and therapeutic potential Int J Biochem Cell Biol 45 2013 2333 2347
19. M. Stout, G.A. Tew, and H. Doll Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study Am Heart J 164 2012 893 901
20. M.R. Mehra, C.J. Lavie, H.O. Ventura, and R.V. Milani Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure J Heart Lung Transplant 25 2006 834 838
21. C.J. Lavie, R.V. Milani, M.R. Mehra, and H.O. Ventura Omega-3 polyunsaturated fatty acids and cardiovascular diseases J Am Coll Cardiol 54 2009 585 594